LILRB2 and hepatocellular carcinoma: Then, in HCC and primary liver cells with ANGPTL8 OE or cultured with rANGPTL8, treatment with an anti-LILRB2/PIRB antibody inhibited ERK phosphorylation and autophagy (Figs. 6D and S18).